Insider Selling: Phreesia, Inc. (NYSE:PHR) Insider Sells 993 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Yvonne Hui sold 993 shares of Phreesia stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $23.04, for a total value of $22,878.72. Following the sale, the insider now directly owns 23,922 shares in the company, valued at $551,162.88. This trade represents a 3.99 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Yvonne Hui also recently made the following trade(s):

  • On Tuesday, April 15th, Yvonne Hui sold 314 shares of Phreesia stock. The shares were sold at an average price of $24.04, for a total transaction of $7,548.56.
  • On Tuesday, April 8th, Yvonne Hui sold 1,878 shares of Phreesia stock. The stock was sold at an average price of $23.85, for a total transaction of $44,790.30.
  • On Friday, January 24th, Yvonne Hui sold 127 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total transaction of $3,556.00.

Phreesia Stock Performance

Phreesia stock opened at $24.19 on Thursday. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The company's 50-day moving average is $25.72 and its 200 day moving average is $24.32. The firm has a market capitalization of $1.42 billion, a P/E ratio of -16.46 and a beta of 0.82. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74.

Wall Street Analysts Forecast Growth




Several equities research analysts have recently issued reports on the company. KeyCorp reduced their target price on Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and lifted their price objective for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. DA Davidson decreased their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Citigroup raised their target price on shares of Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a report on Friday, January 10th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $31.33.

Read Our Latest Research Report on Phreesia

Hedge Funds Weigh In On Phreesia

Several hedge funds have recently bought and sold shares of the business. Invesco Ltd. boosted its stake in shares of Phreesia by 0.9% during the fourth quarter. Invesco Ltd. now owns 40,249 shares of the company's stock valued at $1,013,000 after purchasing an additional 357 shares during the period. NewEdge Advisors LLC lifted its holdings in Phreesia by 12.1% during the 4th quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock valued at $107,000 after buying an additional 459 shares in the last quarter. QRG Capital Management Inc. boosted its position in Phreesia by 8.0% in the 1st quarter. QRG Capital Management Inc. now owns 11,118 shares of the company's stock valued at $284,000 after buying an additional 827 shares during the period. Johnson Financial Group Inc. grew its stake in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock worth $28,000 after acquiring an additional 896 shares in the last quarter. Finally, R Squared Ltd bought a new position in Phreesia in the 4th quarter worth about $30,000. Institutional investors own 92.10% of the company's stock.

Phreesia Company Profile

(Get Free Report)

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

Recommended Stories

Insider Buying and Selling by Quarter for Phreesia (NYSE:PHR)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.

Insider Buying or Selling at Phreesia?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Phreesia and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles